IBL Group

IBL Group

We acquired Skylight Biotech Inc.and established Neosilk Cosmetics Co., Ltd. in 2013. We have made efforts to enhance the synergy of the IBL-group and achieve our goals through our four core businesses (Diagnostic and Research Reagent Business, Transgenic Silkworm-based Protein Production Business, Testing Business, and Cosmetic Business).

Immuno-Biological Laboratories Co., Ltd.

I Diagnostic and Research Reagents Business

Image

We provide research reagents and materials for in-vitro diagnostic products, and license our antibodies to researchers who conduct research in the fields with unmet medical needs.

Click Here to Learn More

II Protein Production Business using Transgenic Silkworms

image

We aim to supply various high-quality proteins, including antibodies produced from cocoons using transgenic silkworms, at reasonable prices to vaccine makers, pharmaceutical companies and manufactures of diagnostic products.

Click Here to Learn More

III Testing Business

research, prevention and diagnosis of lifestyle diseases.

Skylight Biotech Inc. provides solutions for the research, prevention and diagnosis of lifestyle diseases.

Click Here to Learn More

Consolidated Subsidiary

Skylight Biotech

Skylight Biotech

Click Here to Learn More

IV Cosmetic Business

Cosmetic Business

Cosmetics containing Neosilk-Human Collagen I that are produced from the silk of transgenic silkworms are distributed through multiple channels.

Click Here to Learn More

Consolidated Subsidiary

neo silk cosmetics

Neosilk Cosmetics Co., Ltd.

Click Here to Learn More

Distributing Drug related Products
Affiliate Company

Cell Remover Co., Ltd.